Head to Head Comparison: Rennova Health (OTCMKTS:RNVA) and Nyxoah (NASDAQ:NYXH)

Nyxoah (NASDAQ:NYXH) and Rennova Health (OTCMKTS:RNVA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Nyxoah and Rennova Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1	0	4	0	2.60
Rennova Health	0	0	0	0	0.00

Nyxoah presently has a consensus price target of $11.25, suggesting a potential upside of 252.66%. Given Nyxoah’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Nyxoah is more favorable than Rennova Health.

Volatility & Risk

Nyxoah has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, Rennova Health has a beta of 22.86, meaning that its share price is 2,186% more volatile than the S&P 500.

Earnings and Valuation

This table compares Nyxoah and Rennova Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$10.02 million	12.34	-$101.92 million	($2.68)	-1.19
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A

Rennova Health has higher revenue and earnings than Nyxoah.

Profitability

This table compares Nyxoah and Rennova Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyxoah	-884.69%	-139.18%	-79.53%
Rennova Health	N/A	N/A	N/A

Summary

Rennova Health beats Nyxoah on 6 of the 9 factors compared between the two stocks.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.